Evenity (Romosozumab) East Asian Safety Profile Differences
A clinical review of what is and is not known about romosozumab safety, efficacy, cardiovascular risk, and dosing in East Asian patients.
Ethnicity Romosozumab
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
5articles
3topic areas covered
Jul 29, 2026latest review
Ethnicity Romosozumab library
Showing 5 of 5 clinical reviews.
Evenity (Romosozumab) Hispanic / Latino Documented Efficacy Gaps
A clinical review of romosozumab efficacy differences in Hispanic and Latino patients, covering ethnicity-stratified trial subgroup data, pharmacogenomics, diabetes-related bone phenotypes, and what prescribers should monitor.
Evenity (Romosozumab) Hispanic / Latino Dose Adjustments
Does romosozumab require dose adjustments for Hispanic or Latino patients? Review the pharmacology, trial subgroup data, and clinical guidance for Evenity dosing across populations.
Evenity (Romosozumab) in Black / African Ancestry Patients: Safety Profile Differences
Evidence-based review of romosozumab (Evenity) safety, efficacy, and pharmacogenomic considerations specific to Black and African ancestry patients, including cardiovascular risk data and dosing guidance.
Evenity (Romosozumab) in South Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations
Evidence-based review of romosozumab efficacy in South Asian populations, including pharmacogenomic factors, dosing considerations, bone density response data, and cardiovascular risk context.